We are developing sustainable and scalable harvesting and biorefining methods for production of kelp-based ingredients for pharmaceutical and nutraceutical applications. Our objective is to achieve total utilisation of the kelp downstream and become a leading, large-scale manufacturer and supplier of high-quality and unique kelp-based ingredients to a global customer base consisting mainly of end-user production companies spread over several established market segments.
Read more at www.alginor.no

Our ownership stake in Alginor is 21%, making us the second largest shareholder after Borregaard.Our ownership stake in Alginor is 21%, making us the second largest shareholder after Borregaard. We believe Alginor will build a successful and forward-looking business based on biorefining of Norwegian marine raw materials on the west coast of Norway.
– Must AS